| |
| Issue |
Title |
| |
| No 4 (2014) |
INVERSE AGONISTS: MORE THAN JUST ANTAGONISTS? |
Abstract
PDF (Rus)
|
|
R. N. Alyautdin, B. K. Romanov |
| |
| No 4 (2014) |
Transformation of views on the teratogenic effects of antiepileptic drugs |
Abstract
PDF (Rus)
|
|
E. Yu. , R. N. Alyautdin, B. K. Romanov |
| |
| No 4 (2014) |
RETRACTED: Herpes Zoster in RA Patient treated with methotrexate |
Abstract
PDF (Rus)
|
|
Yu. V. Muraviev, G. I. Gridneva |
| |
| No 4 (2014) |
Good Pharmacovigilance Practice in the United States and the European Union |
Abstract
PDF (Rus)
|
|
V. A. Merkulov, N. D. Bunyatyan, A. P. Pereverzev |
| |
| No 4 (2014) |
Problematic aspects of participation of pharmacists in the system of pharmacovigilance in Russia |
Abstract
PDF (Rus)
|
|
E. N. Tkhoseva, T. E. Morozova, O. A. Vartanova, S. M. Rykova, T. B. Andruschishina, D. A. Ermakov, S. M. Oshorova |
| |
| No 3 (2014) |
ON THE IMPACT OF DRUG NAMES AND LABELS ON THE RISK OF MEDICATION ERRORS |
Abstract
PDF (Rus)
|
|
R. N. Alyautdin, A. P. Pereverzev, B. K. Romanov, N. D. Bunyatyan |
| |
| No 3 (2014) |
ADVERSE DRUG REACTIONS IN CRIMEA REPUBLIC IN 2013 |
Abstract
PDF (Rus)
|
|
O. I. Koniaieva, O. V. Matvieiev |
| |
| No 3 (2014) |
PHARMACOEPIDEMIOLOGICAL STUDIES OF ADVERSE REACTIONS OF DEVELOPED DRUGS |
Abstract
PDF (Rus)
|
|
E. J. Kolesnikova |
| |
| No 3 (2014) |
USE OF DRUGS DURING THE FIRST TRIMESTER OF PREGNANCY IN TERMS OF FOETUS SAFETY: ANALYSIS OF PRESCRIBINGS |
Abstract
PDF (Rus)
|
|
A. P. Pereverzev, A. N. Mironov, N. D. Bunyatyan, V. K. Lepakhin, B. K. Romanov |
| |
| No 2 (2014) |
Nanoparticle albumin-bound paclitaxel – first step of nanotechnology into clinical practice |
Abstract
PDF (Rus)
|
|
R. N. Alyautdin, B. K. Romanov, В. К. Лепахин, N. D. Bunyatyan, V. A. Merkulov, A. N. Mironov |
| |
| No 2 (2014) |
Benefit-risk assessment of BCG vaccine in Russia: “Principle of three” method |
Abstract
PDF (Rus)
|
|
I. I. Snegiryova, K. E. Zatolochina, B. K. Romanov |
| |
| No 2 (2014) |
Qualitative methods of benefit / risk assessment |
Abstract
PDF (Rus)
|
|
A. P. Pereverzev, A. N. Mironov, N. D. Bunyatyan, V. K. Lepakhin, B. K. Romanov |
| |
| No 2 (2014) |
Medication errors |
Abstract
PDF (Rus)
|
|
B. K. Romanov, I. A. Toropova, E. Y. Kolesnikova |
| |
| No 2 (2014) |
Retrospective analysis of reports on psychopharmaceuticals drugs safety to identify cases of off-label |
Abstract
PDF (Rus)
|
|
E. O. Zhuravleva, V. A. Polivanov |
| |
| No 3 (2014) |
Dosis facit venenum |
Abstract
PDF (Rus)
|
|
R. N. Alyautdin R.N, B. K. Romanov |
| |
| No 3 (2014) |
Monitoring of drug safety |
Abstract
PDF (Rus)
|
|
B. K. Romanov, S. V. Glagolev, V. A. Polivanov, M. V. Leonova |
| |
| No 2 (2014) |
On the safety of acetaminophen |
Abstract
PDF (Rus)
|
|
R. N. Alyautdin, V. K. Lepakhin, B. K. Romanov, A. P. Pereverzev |
| |
| No 1 (2014) |
THE EFFICACY AND SAFETY PROFILE OF ADVANCED THERAPY MEDICINAL PRODUCTS IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION |
Abstract
PDF (Rus)
|
|
R. N. Alyautdin, B. K. Romanov, V. K. Lepakhin, V. A. Merculov, N. A. Mironov |
| |
| No 1 (2014) |
LOCAL ANESTHETIC MYOTOXICITY |
Abstract
PDF (Rus)
|
|
B. K. Romanov, A. P. Pereverzev, A. N. Mironov, N. D. Bunyatyan, V. K. Lepakhin |
| |
| No 1 (2014) |
INTERSTICIAL PNEUMONITIS, CAUSED BY PEGYLATED INTERFERON ALFA-2A IN A 4 MONTHS CHILD WITH GIGANTIC KAPOSI'S HAEMANGIOEPITHELIOM AND KASABACH – MERRIT PHENOMENON: A CASE REPORT |
Abstract
PDF (Rus)
|
|
S. S. Postnikov, Yu. A. Polyaev, A. A. Mylnikov, A. N. Gricianskaya, M. N. Kostyleva, D. V. Rogogyn |
| |
| No 1 (2014) |
HERPES ZOSTER IN RA PATIENT TREATED WITH METHOTREXATE |
Abstract
PDF (Rus)
|
|
Yu. V. Muraviev, G. I. Gridneva |
| |
| No 4 (2015) |
Recommendations for evaluating the safety of medicinal products containing nanoparticles |
Abstract
PDF (Rus)
|
|
R. N. Alyautdin, B. K. Romanov |
| |
| No 4 (2016) |
«Propofol infusion syndrome» - case in a child of 10 years |
Abstract
PDF (Rus)
|
|
S. S. Postnikov, M. N. Kostyleva, G. P. Bryusov |
| |
| Vol 5, No 4 (2017) |
Problems of interchangeability of systemic interferons for treatment of multiple sclerosis |
Abstract
PDF (Rus)
|
|
I. I. Snegireva, E. Yu. Pasternak, K. E. Zatolochina, M. A. Darmostukova, R. N. Alyautdin, V. A. Polivanov |
| |
| No 1 (2015) |
RISK ASSESSMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS |
Abstract
PDF (Rus)
|
|
R. N. Alyautdin, B. K. Romanov, A. N. Yavorsky, N. D. Bunyatyan, V. A. Merkulov, A. N. Mironov |
| |
| No 4 (2015) |
Checking and correction of drug information in the standards of care and clinical guidelines |
Abstract
PDF (Rus)
|
|
B. K. Romanov |
| |
| No 4 (2016) |
Modern methods of identification of adverse events associated with medication errors |
Abstract
PDF (Rus)
|
|
A. P. Pereverzev, S. K. Zyryanov, Y. Sh. Guschina |
| |
| Vol 5, No 4 (2017) |
Evaluation of the effect of the carrier of polymorphic variants of the SLCO1B1 gene on efficacy and safety in patients during treatment with statins |
Abstract
PDF (Rus)
|
|
N. A. Rumyantsev, Yu. V. Olefir, V. G. Kukes |
| |
| No 1 (2015) |
ON THE QUESTION OF THE DEVELOPMENT OF FETAL CONGENITAL MALFORMATIONS IN THE CONDITIONS OF PREVENTIVE USE BY MOTHERS OF FOLIC ACID IN THE PERINATAL PERIOD |
Abstract
PDF (Rus)
|
|
I. A. Toropova, R. N. Alyautdin, O. S. Alyautdina, B. K. Romanov |
| |
| No 1 (2016) |
The revision of the restrictive lists of medicinal products |
Abstract
PDF (Rus)
|
|
B. K. Romanov, Yu. V. Olefir, V. A. Merkulov, Y. O. Pegova |
| |
| No 4 (2016) |
Combined oral contraceptives: evolution of the relationship benefit/risk |
Abstract
PDF (Rus)
|
|
O. S. Alyautdina |
| |
| Vol 5, No 4 (2017) |
Social media as a source of information on drug safety and how to extract it |
Abstract
PDF (Rus)
|
|
I. I. Snegireva, A. S. Kazakov, E. Yu. Pasternak, K. E. Zatolochina, T. V. Romanova |
| |
| No 1 (2015) |
THE LABELLING OF THE CONTAINERS FOR STORAGE AND TRANSPORTATION OF MEDICINAL PRODUCTS |
Abstract
PDF (Rus)
|
|
A. P. Pereverzev, B. K. Romanov |
| |
| No 1 (2016) |
Perfection of management principles by the safety signals of medicinal products |
Abstract
PDF (Rus)
|
|
B. K. Romanov, V. K. Lepakhin, E. O. Zhuravleva, A. V. Astakhova, S. V. Glagolev, V. A. Polivanov |
| |
| No 4 (2016) |
Ketoacidosis as unexpected adverse reaction SGLT2 inhibitor |
Abstract
PDF (Rus)
|
|
T. M. Bukatina, A. S. Kazakov, N. Yu. Velts, M. A. Darmostukova, K. E. Zatolochina, R. N. Alyautdin, V. P. Dobrynin, B. K. Romanov |
| |
| Vol 5, No 4 (2017) |
Safety of apremilast: risk of psychical disorders |
Abstract
PDF (Rus)
|
|
T. M. Bukatina, N. Yu. Velts, M. A. Darmostukova, E. Yu. Pasternak, T. V. Romanova |
| |
| No 1 (2015) |
SUGGESTIONS FOR PREVENTING UNDESIRED REACTIONS AT APPLICATION IMMUNOBIOLOGICAL MEDICINAL PRODUCTS IN THE RUSSIAN FEDERATION |
Abstract
PDF (Rus)
|
|
N. A. Ozeretskovsky, K. E. Zatolochina, I. I. Snegireva |
| |
| No 1 (2016) |
The risk management system as the important part of good pharmacovigilance practices (GVP) |
Abstract
PDF (Rus)
|
|
A. S. Kazakov, K. E. Zatolochina, B. K. Romanov, T. M. Bukatina, N. Yu. Velts |
| |
| No 4 (2016) |
The risk of an acute attack of angle-closure glaucoma during the treatment with modern antidepressant drugs |
Abstract
PDF (Rus)
|
|
T. V. Romanova, T. M. Bukatina, N. Yu. Velts, E. Yu. Pasternak, A. S. Kazakov, M. A. Darmostukova, R. N. Alyautdin, B. K. Romanov |
| |
| No 1 (2015) |
COMPARATIVE EVALUATION OF INFORMATION ON ADVERSE REACTIONS TO MEDICINES |
Abstract
PDF (Rus)
|
|
V. K. Lepakhin, A. P. Pereverzev, B. K. Romanov |
| |
| No 1 (2016) |
The rules of good laboratory practice |
Abstract
PDF (Rus)
|
|
N. Yu. Velts, R. N. Alyautdin, A. S. Kazakov, T. M. Bukatina, M. A. Darmostukova |
| |
| No 4 (2016) |
Information on the decisions of foreign regulatory authorities |
Abstract
PDF (Rus)
|
|
T. M. Bukatina, E. Yu. Pasternak, B. K. Romanov, R. N. Alyautdin, V. K. Lepakhin, A. S. Kazakov, K. E. Zatolochina, I. I. Snegireva, M. A. Darmostukova, E. Yu. Kolesnikova, E. O. Zhuravleva, T. V. Romanova, N. Yu. Velts, M. L. Maksimov, G. V. Kutekhova |
| |
| No 2 (2015) |
ADVERSE EVENTS OF INTERFERONS WITH SYSTEMIC EFFECT |
Abstract
PDF (Rus)
|
|
A. A. Toporov, A. S. Kolbin |
| |
| No 1 (2016) |
The risk of milk thistle (Silybum marianum) drug interactions |
Abstract
PDF (Rus)
|
|
A. S. Kazakov, K. E. Zatolochina, E. Yu. Kolesnikova, O. E. Zhuravleva |
| |
| Vol 5, No 1 (2017) |
The results of the analysis of materials on the safety of clinical trials |
Abstract
PDF (Rus)
|
|
Yu. V. Olefir |
| |
| No 2 (2015) |
ON THE SAFETY OF ANTIBACTERIAL DRUGS USED IN PEDIATRICS |
Abstract
PDF (Rus)
|
|
A. R. Titova, E. Y. Pasternak, I. L. Asetskaya, S. K. Zyryanov, V. A. Polivanov, R. N. Alyautdin, B. K. Romanov |
| |
| No 2 (2016) |
On the interchangeability of calcineurine inhibitors |
Abstract
PDF (Rus)
|
|
K. E. Zatolochina, R. N. Alyautdin, E. O. Zhuravleva, E. Yu. Pasternak, M. A. Darmostukova, E. Yu. Kolesnikova, B. K. Romanov |
| |
| Vol 5, No 1 (2017) |
SGLT2 inhibitors: control of glycemia and nephroprotection properties |
Abstract
PDF (Rus)
|
|
A. A. Volodin, M. L. Maximov, V. G. Slobodyan, R. N. Alyautdin |
| |
| No 2 (2015) |
THE SAFETY ASSESSMENT OF MEDICINAL PLANTS |
Abstract
PDF (Rus)
|
|
E. V. Shikh, V. M. Bulayev, O. A. Demidova |
| |
| No 2 (2016) |
Typical pharmacovigilance system master file (PSMF) |
Abstract
PDF (Rus)
|
|
B. K. Romanov, R. N. Alyautdin, S. V. Glagolev, V. A. Polivanov |
| |
| 1 - 50 of 72 Items |
1 2 > >>
|
